Prognostic impact of micrometastases in colon cancer: Interim results of a prospective multicenter trial

Annals of Surgery

Volumn 246, Issue 4, 2007, Pages 568-575

  Bilchik, Anton J ^a   Hoon, Dave S B ^a   Saha, Sukamal ^b   Turner, Roderick R ^a   Wiese, David ^b   DiNome, Maggie ^a   Koyanagi, Kazuo ^a   McCarter, Martin ^c   Shen, Perry ^d   Iddings, Douglas ^a   Chen, Steven L ^a   Gonzalez, Maria ^a   Elashoff, David ^a   Morton, Donald L ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN;

AGED; ARTICLE; CLINICAL TRIAL; COLON CANCER; COLON RESECTION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; RECURRENT CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; TUMOR BIOPSY;

AGED; COLECTOMY; COLONIC NEOPLASMS; COLORING AGENTS; DISEASE-FREE SURVIVAL; FEMALE; FLUORESCENT DYES; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPHATIC METASTASIS; MALE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

EID: 34748814911     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318155a9c7     Document Type: Article

References (43)

1. Jemel A, Ward S, Murray T, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006;244:602-610.
3. Rodriguez-Bigas MA, Maamoun S, Weber TK, et al. Clinical signifi-cance of colorectal cancer: metastases in lymph nodes <5mm in size. Ann Surg Oncol. 1996;3:124-130.
4. Cawthorn SJ, Gibbs NM, Marks CG. Clearance technique for the detection of lymph nodes in colorectal cancer. Br J Surg. 1986;73:58-60.
5. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
6. Morton DL, Hoon DSB, Cochran A, et al. Long-term results of lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: in 1599 patients: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg. 2003;238:538-549.
7. Posther KE, McCall LM, Blumencranz PW, et al. Sentinel node skills verification and surgeon performance: data from multicenter clinical trial for early-stage breast cancer. Ann Surg. 2005;242:593-599.
8. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-1317.
9. Gabriel W, Dukes C, Bussey H. Lymphatic spread in cancer of the rectum. Br J Surg. 1935;23:395-413.
10. Bilchik AJ, DiNome M, Saha S, et al. Prospective multicenter trial of staging adequacy in colon cancer. Arch Surg. 2006;141:527-534.
11. Green FL, Page DL, Fleming ID, et al, eds. Cancer Staging Manual. 6th ed. New York, NY: Springer Verlag; 2002.
12. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumors. 6th ed. New York, NY: Wiley; 2002.
13. Takeuchi H, Bilchik A, Saha S, et al. Quantitative c-MET mRNA expression in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Clin Cancer Res. 2003;9:1480-1488.
14. Takeuchi H, Taback B, Kuo C, et al. Clinicopathological utility of molecular staging of cancer patients undergoing sentinel lymphadenectomy. Ann Surg Oncol. 2004;11:152S-155S.
15. Bilchik AJ, Nora D, Tollenaar RAEM, et al. Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer. 2002;38:977-985.
16. Bilchik AJ, Saha S, Wiese D, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol. 2001;19:1128-1136.
17. Nakanishi Y, Ochiai A, Yamauchi Y, et al. Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study. Oncology. 1999;57:276-280.
18. Tschmelitsch J, Klimstra DS, Cohen AM. Lymph node micrometastases do not predict relapse in stage II colon cancer. Ann Surg Oncol. 2000;7:601-608.
19. Yasuda K, Adachi Y, Shiraishi N, et al. Pattern of lymph node micro-metastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol. 2001;8:300-304.
20. Clarke G, Ryan E, O'Keane JC, et al. The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome. Eur J Gastroenterol Hepatol. 2000;12:549-552.
21. Davidson BR, Sams VR, Styles J, et al. Detection of occult nodal metastases in patients with colorectal carcinoma. Cancer. 1990;15:65:967-970.
22. Hayashi N, Ito I, Yanagisawa A, et al. Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet. 1995;345:1257-1259.
23. Adell G, Boeryd B, Franlund B, et al. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg. 1996;162:637-642.
24. Haboubi NY, Abdalla SA, Amini S, et al. The novel combination of fat clearance and immunohistochemistry improves prediction of the outcome of patients with colorectal carcinomas: a preliminary study. Int J Colorectal Dis. 1998;13:99-102.
25. Isaka N, Nozue M, Doy M, et al. Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin Cancer Res. 1999;5:2065-2068.
26. Mori M, Mimori K, Inoue H, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995;55:3417-3420.
27. Noura S, Yamamoto H, Miyake Y, et al. Immunohistochemical assessment of localization and frequency of micrometastasis in lymph nodes of colorectal cancer. Clin Cancer Res. 2002;8:759-767.
28. Palma RT, Waisberg J, Bromberg SH, et al. Micrometastasis in regional lymph nodes of extirpated colorectal carcinoma: immunohistochemical study using anti-cytokeratin antibodies AE1/AE3. Colorectal Dis. 2003; 5:164-168.
29. Sasaki M, Watanabe H, Jass JR, et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node negative" colorectal cancer. J Gastroenterol. 1997;32:758-764.
30. Noura S, Yamamoto H, Ohnishi T, et al. Comparative detection of lymph node micrometastasis of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistery. J Clin Oncol. 2002;20:4232-4241.
31. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, et al. Micrometastasis and survival in stage II colorectal cancer. N Engl J Med. 1998;339:223-228.
32. Rosenberg R, Hoos A, Mueller J, et al. Prognostic significance of cytokeratin-20 reverse-transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol. 2002; 20:1049-1055.
33. Iddings DM, Ahmad A, Elashoff D, et al. The prognostic effect of micrometastases in previously staged lymph node-negative colorectal carcinoma: a meta-analysis. Ann Surg Oncol. 2006;13:1386-1392.
34. Prandi M, Lionetto R, Bini A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy. Results of a secondary analysis of a large scale adjuvant trial. Ann Surg. 2002;235:458-463.
35. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912-2919.
36. Swanson RS, Compton CC, Stewart AK, et al. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10:65-71.
37. Sargent DJ, Goldberg RM, Jacobson SD, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001;345:1091-1097.
38. Gill S, Loprinzi C, Sargent D, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 2004;22:1797-1806.
39. Bilchik AJ, Nora DT, Sobin LH, et al. Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer. J Clin Oncol. 2003;21:668-672.
40. Joosten JJ, Strobbe LJ, Wauter CA, et al. Intraoperative lymphatic mapping and sentinel lymph node concept in colorectal carcinoma. Br J Surg. 1999;86:482-486.
41. Merrie AE, van Rij AM, Phillips LV, et al. Diagnostic use of sentinel node in colon cancer. Dis Colon Rectum. 2001;44:410-417.
42. Bertagnolli M, Miedema B, Redston M, et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg. 2004;240:624-630.
43. Redston M, Compton CC, Miedema BW, et al. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001. J Clin Oncol. 2006;24:878-883.